EFAVIRENZ

EFAVIRENZ was reported 11103 times

EFAVIRENZ is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PAROXYSMAL EXTREME PAIN DISORDER 17 0.6800
1 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA 72 0.5581
2 ULTRASOUND ANTENATAL SCREEN 51 0.5312
3 HEPATIC DISPLACEMENT 11 0.4583
4 DIAPHRAGMATIC APLASIA 11 0.4231
5 HYDRANENCEPHALY 10 0.4167
6 PACHYGYRIA 15 0.4167
7 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 39 0.3514
8 RETROVIRAL REBOUND SYNDROME 8 0.3478
9 SPINOCEREBELLAR DISORDER 15 0.3191
10 HIV VIRAEMIA 58 0.2762
11 AIDS ENCEPHALOPATHY 16 0.2759
12 ENDOMETRIAL SARCOMA 7 0.2414
13 CARDIAC MALPOSITION 18 0.2368
14 CD4 LYMPHOCYTES 6 0.2222
15 TUBERCULOID LEPROSY 14 0.2154
16 IMMUNE RECONSTITUTION SYNDROME 278 0.2153
17 VIRAL MUTATION IDENTIFIED 676 0.1833
18 VIROLOGIC FAILURE 958 0.1780
19 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 57 0.1701
20 CONGENITAL DIAPHRAGMATIC ANOMALY 6 0.1667
21 PREMATURE CLOSURE OF CRANIAL SUTURES 6 0.1579
22 BIRTH MARK 32 0.1538
23 CENTRAL NERVOUS SYSTEM IMMUNE RECONSTITUTION INFLAMMATORY RESPONSE 6 0.1429
24 ISOSPORIASIS 11 0.1410
25 GENITAL PROLAPSE 7 0.1250
26 AIDS RELATED COMPLICATION 8 0.1231
27 MITOCHONDRIAL TOXICITY 101 0.1230
28 TRISOMY 18 46 0.1207
29 HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION 33 0.1187
30 HIV ASSOCIATED NEPHROPATHY 6 0.1176
31 CONFUSIONAL AROUSAL 18 0.1118
32 SECONDARY SYPHILIS 11 0.1111
33 LIPODYSTROPHY ACQUIRED 230 0.1082
34 CASTLEMAN'S DISEASE 6 0.1034
35 CONGENITAL UMBILICAL HERNIA 36 0.0965
36 POST PROCEDURAL HYPOTHYROIDISM 18 0.0849
37 HYDROPS FOETALIS 52 0.0848
38 TUBERCULOMA OF CENTRAL NERVOUS SYSTEM 15 0.0824
39 CD4 LYMPHOCYTES INCREASED 19 0.0815
40 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 381 0.0764
41 SYNOSTOSIS 8 0.0762
42 PATHOGEN RESISTANCE 642 0.0704
43 MENINGOENCEPHALITIS VIRAL 12 0.0678
44 DYSDIADOCHOKINESIS 11 0.0643
45 DEFORMITY THORAX 12 0.0622
46 DIASTASIS RECTI ABDOMINIS 9 0.0559
47 NEUROSYPHILIS 8 0.0526
48 CHRONIC RESPIRATORY DISEASE 18 0.0510
49 BLOOD HIV RNA INCREASED 91 0.0501
50 KAPOSI'S SARCOMA 25 0.0498
51 MENINGITIS TUBERCULOUS 27 0.0483
52 COLLATERAL CIRCULATION 7 0.0483
53 ENCEPHALOCELE 12 0.0482
54 EXTRAPULMONARY TUBERCULOSIS 14 0.0475
55 CONGENITAL HYDROCEPHALUS 24 0.0473
56 CLEFT LIP AND PALATE 52 0.0465
57 LIPOATROPHY 43 0.0452
58 GENOTYPE DRUG RESISTANCE TEST POSITIVE 46 0.0447
59 PNEUMOCYSTIS CARINII PNEUMONIA 9 0.0443
60 CSF HIV ESCAPE SYNDROME 6 0.0435
61 APLASIA CUTIS CONGENITA 6 0.0420
62 EPIDERMODYSPLASIA VERRUCIFORMIS 7 0.0417
63 MITOCHONDRIAL MYOPATHY 9 0.0413
64 RETINAL TOXICITY 42 0.0408
65 DEGENERATIVE BONE DISEASE 18 0.0406
66 MENINGITIS CRYPTOCOCCAL 70 0.0400
67 MENINGOMYELOCELE 24 0.0400
68 CONDUCTIVE DEAFNESS 12 0.0374
69 ACID FAST BACILLI INFECTION 6 0.0373
70 BIOPSY LIVER ABNORMAL 11 0.0367
71 URINARY TRACT INFLAMMATION 13 0.0361
72 NODULAR REGENERATIVE HYPERPLASIA 23 0.0358
73 PORTAL HYPERTENSIVE GASTROPATHY 20 0.0355
74 LYMPH NODE TUBERCULOSIS 26 0.0349
75 ACQUIRED IMMUNODEFICIENCY SYNDROME 18 0.0347
76 CEREBELLAR ATAXIA 33 0.0344
77 NEURAL TUBE DEFECT 24 0.0330
78 MUSCULOSKELETAL TOXICITY 6 0.0323
79 NON-CIRRHOTIC PORTAL HYPERTENSION 12 0.0319
80 FANCONI SYNDROME ACQUIRED 56 0.0319
81 NONALCOHOLIC FATTY LIVER DISEASE 6 0.0306
82 EXTRAOCULAR MUSCLE PARESIS 14 0.0305
83 CENTRAL NERVOUS SYSTEM INFLAMMATION 10 0.0301
84 RENAL TUBULAR DYSFUNCTION 17 0.0301
85 FACIAL WASTING 8 0.0297
86 PSYCHIATRIC DECOMPENSATION 58 0.0297
87 HIV INFECTION 88 0.0292
88 DRUG RESISTANCE 742 0.0289
89 ERYTHEMA ANNULARE 8 0.0276
90 UPPER MOTOR NEURONE LESION 6 0.0273
91 FACIAL DYSMORPHISM 6 0.0271
92 CD4 LYMPHOCYTES DECREASED 55 0.0257
93 STILLBIRTH 124 0.0256
94 FANCONI SYNDROME 36 0.0254
95 VANISHING BILE DUCT SYNDROME 28 0.0251
96 MULTIPLE-DRUG RESISTANCE 77 0.0248
97 PULMONARY TUBERCULOSIS 102 0.0239
98 SKULL MALFORMATION 15 0.0233
99 PORTAL HYPERTENSION 72 0.0233
100 POLYDACTYLY 27 0.0233
101 MALARIA 16 0.0227
102 CYTOMEGALOVIRUS CHORIORETINITIS 44 0.0225
103 CEREBRAL TOXOPLASMOSIS 21 0.0225
104 OPHTHALMOPLEGIA 34 0.0215
105 GRAFT DYSFUNCTION 6 0.0211
106 NEUROPSYCHIATRIC SYMPTOMS 19 0.0210
107 EXOMPHALOS 11 0.0205
108 NECROTISING RETINITIS 13 0.0203
109 DYSLIPIDAEMIA 102 0.0201
110 HYDROCELE 21 0.0197
111 CYSTITIS NONINFECTIVE 26 0.0194
112 SYPHILIS 14 0.0193
113 BASEDOW'S DISEASE 9 0.0191
114 HYPERTELORISM OF ORBIT 8 0.0191
115 TUBERCULOSIS GASTROINTESTINAL 6 0.0188
116 CRYPTOCOCCOSIS 30 0.0184
117 PORPHYRIA NON-ACUTE 8 0.0184
118 MITOCHONDRIAL CYTOPATHY 8 0.0182
119 ACUTE STRESS DISORDER 6 0.0180
120 VIRAL LOAD INCREASED 69 0.0178
121 GENE MUTATION 34 0.0172
122 HISTOPLASMOSIS 30 0.0169
123 SPINA BIFIDA 35 0.0168
124 VIRAEMIA 23 0.0166
125 NEUROPSYCHOLOGICAL SYMPTOMS 10 0.0166
126 CYTOMEGALOVIRUS OESOPHAGITIS 6 0.0163
127 NEURODEVELOPMENTAL DISORDER 11 0.0163
128 MICROGNATHIA 8 0.0160
129 LIFE EXPECTANCY SHORTENED 9 0.0159
130 BONE TUBERCULOSIS 6 0.0157
131 DEVELOPMENTAL HIP DYSPLASIA 13 0.0156
132 MYCOBACTERIUM AVIUM COMPLEX INFECTION 41 0.0153
133 SCLERAL DISCOLOURATION 10 0.0152
134 VISCERAL LEISHMANIASIS 11 0.0152
135 LIPIDS ABNORMAL 11 0.0152
136 DISEASE RISK FACTOR 6 0.0149
137 ANKYLOGLOSSIA CONGENITAL 6 0.0149
138 MOLLUSCUM CONTAGIOSUM 8 0.0148
139 LIPOHYPERTROPHY 9 0.0145
140 GENE MUTATION IDENTIFICATION TEST POSITIVE 6 0.0143
141 ANENCEPHALY 8 0.0142
142 HYPERLACTACIDAEMIA 38 0.0142
143 PLAGIOCEPHALY 7 0.0140
144 HEPATOSPLENOMEGALY 36 0.0140
145 SUPERINFECTION BACTERIAL 11 0.0139
146 DEATH NEONATAL 19 0.0136
147 CONGENITAL MUSCULOSKELETAL ANOMALY 6 0.0136
148 CSF PROTEIN INCREASED 11 0.0133
149 OVARIAN FAILURE 7 0.0131
150 TWIN PREGNANCY 11 0.0131
151 SICKLE CELL DISEASE 6 0.0130
152 OSTEOMALACIA 20 0.0129
153 PANCREATITIS HAEMORRHAGIC 6 0.0129
154 ABORTION INDUCED 121 0.0128
155 HEPATIC FIBROSIS 44 0.0128
156 GASTRIC VARICES 6 0.0127
157 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 14 0.0127
158 PSYCHOMOTOR SKILLS IMPAIRED 33 0.0126
159 BRAIN HERNIATION 37 0.0124
160 DISSEMINATED TUBERCULOSIS 31 0.0121
161 CEREBELLAR SYNDROME 26 0.0119
162 GLYCOSURIA 16 0.0118
163 CHOLESTATIC LIVER INJURY 26 0.0117
164 CRANIOSYNOSTOSIS 10 0.0115
165 CRYPTOSPORIDIOSIS INFECTION 6 0.0114
166 LIMB MALFORMATION 9 0.0114
167 HILAR LYMPHADENOPATHY 10 0.0114
168 ANAL CANCER 11 0.0113
169 CONGENITAL NOSE MALFORMATION 6 0.0113
170 MOUTH INJURY 17 0.0112
171 NEUROTOXICITY 196 0.0112
172 MONOCLONAL GAMMOPATHY 7 0.0112
173 BODY FAT DISORDER 6 0.0111
174 PREGNANCY ON CONTRACEPTIVE 16 0.0110
175 MICROCEPHALY 14 0.0109
176 SYNDACTYLY 9 0.0108
177 HISTOPLASMOSIS DISSEMINATED 17 0.0107
178 RENAL TUBULAR ACIDOSIS 23 0.0105
179 BLOOD AMYLASE INCREASED 18 0.0105
180 ARNOLD-CHIARI MALFORMATION 10 0.0105
181 DEPRESSION SUICIDAL 36 0.0104
182 PLEOCYTOSIS 6 0.0103
183 EYELID PTOSIS 104 0.0102
184 CUSHING'S SYNDROME 7 0.0101
185 ABORTION THREATENED 5 0.0100
186 TEARFULNESS 43 0.0100
187 SJS-TEN OVERLAP 7 0.0100
188 GRANULOMATOUS LIVER DISEASE 7 0.0099
189 PARADOXICAL DRUG REACTION 36 0.0098
190 DEPRESSIVE SYMPTOM 34 0.0096
191 HEPATOBILIARY DISEASE 6 0.0096
192 ADRENAL SUPPRESSION 8 0.0095
193 MENINGITIS VIRAL 13 0.0095
194 ATYPICAL MYCOBACTERIAL INFECTION 13 0.0092
195 CALCULUS URINARY 14 0.0091
196 CHRONIC ALLOGRAFT NEPHROPATHY 7 0.0089
197 RENAL TUBULAR DISORDER 25 0.0089
198 UTERINE DILATION AND CURETTAGE 8 0.0088
199 MARROW HYPERPLASIA 6 0.0088
200 CUSHINGOID 28 0.0087
201 CHRONIC HEPATITIS 7 0.0086
202 VARICES OESOPHAGEAL 26 0.0086
203 GLOMERULAR FILTRATION RATE INCREASED 7 0.0085
204 NEPHROPATHY TOXIC 95 0.0085
205 ECTOPIC PREGNANCY 26 0.0084
206 PREMATURE RUPTURE OF MEMBRANES 20 0.0083
207 OESOPHAGEAL VARICES HAEMORRHAGE 18 0.0083
208 HODGKIN'S DISEASE 6 0.0083
209 APLASIA PURE RED CELL 28 0.0081
210 PREGNANCY WITH IMPLANT CONTRACEPTIVE 38 0.0081
211 PNEUMOCYSTIS JIROVECI PNEUMONIA 18 0.0081
212 TALIPES 25 0.0080
213 CACHEXIA 41 0.0080
214 LIPIDS INCREASED 16 0.0079
215 MYELITIS TRANSVERSE 11 0.0078
216 NORMAL NEWBORN 42 0.0077
217 DEAFNESS BILATERAL 13 0.0076
218 ACQUIRED GENE MUTATION 10 0.0076
219 FOETAL EXPOSURE DURING PREGNANCY 616 0.0076
220 LIVE BIRTH 63 0.0075
221 HYPERTRIGLYCERIDAEMIA 44 0.0075
222 ABORTION SPONTANEOUS 301 0.0075
223 HEPATITIS B 45 0.0075
224 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 8 0.0074
225 PNEUMONIA STREPTOCOCCAL 8 0.0073
226 HYPOPHOSPHATAEMIA 54 0.0073
227 MYCOSIS FUNGOIDES 6 0.0073
228 RED BLOOD CELL ABNORMALITY 7 0.0073
229 HYPERLIPIDAEMIA 87 0.0073
230 AUTOIMMUNE HEPATITIS 49 0.0070
231 OESOPHAGEAL CANDIDIASIS 28 0.0070
232 VITRITIS 13 0.0070
233 CHOREA 12 0.0070
234 FAT TISSUE INCREASED 10 0.0069
235 NIGHT BLINDNESS 11 0.0069
236 POLYHYDRAMNIOS 7 0.0069
237 HEPATOMEGALY 67 0.0068
238 DYSMORPHISM 16 0.0068
239 SECONDARY ADRENOCORTICAL INSUFFICIENCY 10 0.0066
240 PARAINFLUENZAE VIRUS INFECTION 10 0.0066
241 EXTENSOR PLANTAR RESPONSE 6 0.0065
242 PORTAL VEIN THROMBOSIS 21 0.0065
243 BLOOD ELECTROLYTES ABNORMAL 8 0.0065
244 BLOOD LACTIC ACID INCREASED 34 0.0064
245 RETINAL EXUDATES 6 0.0064
246 FOETAL GROWTH RESTRICTION 39 0.0064
247 ABORTION MISSED 8 0.0063
248 MULTIPLE CONGENITAL ABNORMALITIES 9 0.0063
249 INTRA-UTERINE DEATH 10 0.0062
250 LICHENOID KERATOSIS 14 0.0061
251 NON-HODGKIN'S LYMPHOMA 8 0.0061
252 PNEUMONIA PNEUMOCOCCAL 9 0.0061
253 CEREBRAL VENTRICLE DILATATION 7 0.0061
254 HISTIOCYTOSIS HAEMATOPHAGIC 18 0.0061
255 FOLATE DEFICIENCY 7 0.0061
256 HYDROCEPHALUS 33 0.0061
257 PREGNANCY 119 0.0059
258 GENITAL HERPES 9 0.0059
259 CAESAREAN SECTION 68 0.0058
260 MYCOBACTERIAL INFECTION 10 0.0058
261 FOETAL DEATH 30 0.0058
262 POLYMYALGIA RHEUMATICA 18 0.0057
263 ANAEMIA MACROCYTIC 12 0.0056
264 JOINT CONTRACTURE 6 0.0056
265 EXOPHTHALMOS 12 0.0056
266 TOXOPLASMOSIS 6 0.0056
267 GRANULOMA 19 0.0055
268 CEREBRAL ISCHAEMIA 28 0.0054
269 PEPTIC ULCER 18 0.0054
270 PREMATURE DELIVERY 86 0.0054
271 APRAXIA 8 0.0054
272 INTRACRANIAL PRESSURE INCREASED 30 0.0054
273 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 44 0.0053
274 HEPATIC NECROSIS 20 0.0053
275 RENAL COLIC 12 0.0053
276 METABOLIC DISORDER 30 0.0052
277 TREATMENT FAILURE 423 0.0051
278 CENTRAL NERVOUS SYSTEM LYMPHOMA 7 0.0051
279 TREATMENT NONCOMPLIANCE 276 0.0050
280 LIVER TRANSPLANT REJECTION 9 0.0050
281 HEPATITIS TOXIC 13 0.0050
282 BUNDLE BRANCH BLOCK LEFT 21 0.0049
283 VASCULAR STENT THROMBOSIS 10 0.0049
284 HEPATOTOXICITY 109 0.0049
285 METABOLIC SYNDROME 8 0.0049
286 ORAL CANDIDIASIS 64 0.0049
287 LABELLED DRUG-DRUG INTERACTION ISSUE 7 0.0048
288 DRUG INTERACTION 762 0.0048
289 MATERNAL EXPOSURE DURING PREGNANCY 427 0.0048
290 LOW BIRTH WEIGHT BABY 38 0.0048
291 DRUG-INDUCED LIVER INJURY 150 0.0048
292 HEPATITIS C 56 0.0046
293 HEPATITIS 117 0.0046
294 LACTIC ACIDOSIS 148 0.0046
295 CONGESTIVE CARDIOMYOPATHY 19 0.0046
296 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 217 0.0045
297 LUNG CANCER METASTATIC 13 0.0045
298 AREFLEXIA 12 0.0045
299 PARAPARESIS 8 0.0045
300 TRANSPLANT FAILURE 11 0.0045
301 LIMB DEFORMITY 7 0.0044
302 ABORTION INCOMPLETE 8 0.0043
303 HEPATIC ENCEPHALOPATHY 40 0.0043
304 RHINITIS ALLERGIC 19 0.0043
305 TONGUE DISCOMFORT 18 0.0042
306 OSTEOPOROSIS 173 0.0042
307 ENCEPHALITIS 29 0.0042
308 SPLENOMEGALY 49 0.0042
309 OSTEOPOROTIC FRACTURE 8 0.0042
310 LYMPHADENOPATHY MEDIASTINAL 8 0.0042
311 HEPATIC CYTOLYSIS 53 0.0042
312 HEPATITIS CHOLESTATIC 25 0.0041
313 CLEFT PALATE 8 0.0041
314 NERVOUS SYSTEM DISORDER 129 0.0041
315 LYMPHADENITIS 10 0.0041
316 LIVER TRANSPLANT 15 0.0041
317 EXPOSURE DURING PREGNANCY 251 0.0040
318 CREATININE RENAL CLEARANCE DECREASED 16 0.0040
319 HYPERPARATHYROIDISM SECONDARY 10 0.0040
320 MIXED LIVER INJURY 12 0.0040
321 MYOPATHY 34 0.0039
322 DRUG LEVEL ABOVE THERAPEUTIC 18 0.0039
323 BK VIRUS INFECTION 13 0.0039
324 HYPOSPADIAS 8 0.0038
325 SMALL FOR DATES BABY 19 0.0038
326 PREGNANCY ON ORAL CONTRACEPTIVE 10 0.0038
327 OPPORTUNISTIC INFECTION 7 0.0038
328 NECROSIS 21 0.0038
329 HYPERREFLEXIA 13 0.0037
330 HYPERCHOLESTEROLAEMIA 36 0.0037
331 HEPATITIS FULMINANT 11 0.0037
332 FACIAL PALSY 8 0.0037
333 BLOOD BICARBONATE DECREASED 7 0.0037
334 BACTERIAL SEPSIS 12 0.0037
335 ALANINE AMINOTRANSFERASE INCREASED 226 0.0037
336 CERVICAL DYSPLASIA 8 0.0037
337 NASAL POLYPS 18 0.0037
338 ASPARTATE AMINOTRANSFERASE INCREASED 194 0.0036
339 EXPOSURE DURING BREAST FEEDING 12 0.0036
340 MENINGITIS 24 0.0036
341 PARESIS 8 0.0036
342 GAZE PALSY 6 0.0035
343 PNEUMOCYSTIS JIROVECII PNEUMONIA 35 0.0035
344 DRUG LEVEL BELOW THERAPEUTIC 19 0.0034
345 PSYCHOTIC SYMPTOM 7 0.0034
346 MATERNAL DRUGS AFFECTING FOETUS 26 0.0034
347 DIPLOPIA 88 0.0034
348 INSULIN RESISTANCE 7 0.0034
349 GINGIVITIS 18 0.0033
350 OPHTHALMIC HERPES ZOSTER 6 0.0033
351 NEUROLOGICAL SYMPTOM 19 0.0033
352 HEPATIC CIRRHOSIS 62 0.0033
353 BLOOD BILIRUBIN INCREASED 89 0.0033
354 BLOOD PHOSPHORUS DECREASED 12 0.0033
355 CHEST X-RAY ABNORMAL 10 0.0033
356 LYMPH NODE PAIN 6 0.0032
357 PREMATURE BABY 97 0.0032
358 VITAMIN B12 DEFICIENCY 13 0.0032
359 DRUG EXPOSURE DURING PREGNANCY 106 0.0031
360 OSTEOPENIA 47 0.0031
361 ALCOHOL INTERACTION 6 0.0031
362 GAMMA-GLUTAMYLTRANSFERASE INCREASED 67 0.0030
363 CREPITATIONS 9 0.0030
364 ABDOMINAL TENDERNESS 15 0.0030
365 GASTROENTERITIS 44 0.0030
366 PROTEINURIA 57 0.0030
367 TUMOUR LYSIS SYNDROME 26 0.0030
368 SKIN ATROPHY 17 0.0030
369 BLOOD TRIGLYCERIDES INCREASED 52 0.0029
370 FIBROSIS 9 0.0029
371 INTERNATIONAL NORMALISED RATIO FLUCTUATION 6 0.0029
372 VIITH NERVE PARALYSIS 10 0.0029
373 LYMPHOEDEMA 20 0.0029
374 RENAL IMPAIRMENT 241 0.0029
375 MALNUTRITION 32 0.0029
376 LYMPHADENOPATHY 101 0.0029
377 ENCEPHALOPATHY 70 0.0028
378 CONGENITAL ANOMALY 22 0.0028
379 PNEUMONIA BACTERIAL 26 0.0028
380 ACUTE PSYCHOSIS 7 0.0028
381 FOETAL DISTRESS SYNDROME 6 0.0028
382 BLOOD ALKALINE PHOSPHATASE INCREASED 69 0.0028
383 STRABISMUS 8 0.0027
384 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 24 0.0027
385 ACUTE MYOCARDIAL INFARCTION 80 0.0027
386 ACUTE HEPATIC FAILURE 37 0.0027
387 SKIN NECROSIS 14 0.0027
388 RASH MACULO-PAPULAR 60 0.0027
389 RETINOPATHY 10 0.0027
390 PREMATURE LABOUR 15 0.0027
391 JAUNDICE 71 0.0026
392 HEPATOCELLULAR CARCINOMA 20 0.0026
393 TRANSPLANT REJECTION 21 0.0026
394 ATAXIA 31 0.0026
395 DRUG LEVEL INCREASED 43 0.0026
396 CAROTID ARTERY STENOSIS 9 0.0026
397 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 44 0.0026
398 RENAL TUBULAR NECROSIS 25 0.0025
399 PANCREATITIS CHRONIC 6 0.0025
400 PRESCRIBED OVERDOSE 49 0.0025
401 EXPOSURE VIA BREAST MILK 10 0.0025
402 HYPERBILIRUBINAEMIA 26 0.0025
403 LUNG CONSOLIDATION 7 0.0025
404 DIABETES INSIPIDUS 6 0.0025
405 PSYCHOMOTOR RETARDATION 7 0.0025
406 LOW DENSITY LIPOPROTEIN INCREASED 19 0.0025
407 PSYCHOTIC DISORDER 72 0.0024
408 STEVENS-JOHNSON SYNDROME 54 0.0024
409 CYTOLYTIC HEPATITIS 8 0.0024
410 DERMATITIS EXFOLIATIVE 12 0.0024
411 TRANSAMINASES INCREASED 53 0.0024
412 PARANOIA 41 0.0024
413 GLUCOSE TOLERANCE IMPAIRED 14 0.0024
414 PATHOLOGICAL FRACTURE 12 0.0024
415 VITAMIN D DEFICIENCY 23 0.0024
416 VISUAL FIELD DEFECT 17 0.0024
417 PRE-ECLAMPSIA 11 0.0023
418 HEPATIC STEATOSIS 43 0.0023
419 GESTATIONAL DIABETES 11 0.0023
420 RENAL FAILURE ACUTE 97 0.0023
421 HYPERSENSITIVITY VASCULITIS 6 0.0023
422 CEREBRAL ATROPHY 9 0.0023
423 ANOREXIA 29 0.0022
424 SKIN LESION 61 0.0022
425 BEHAVIOUR DISORDER 12 0.0022
426 PAPILLOEDEMA 10 0.0022
427 GOITRE 9 0.0022
428 ANAEMIA 411 0.0022
429 RENAL FUNCTION TEST ABNORMAL 10 0.0022
430 HELICOBACTER INFECTION 22 0.0021
431 LUNG NEOPLASM 9 0.0021
432 LEFT VENTRICULAR DYSFUNCTION 14 0.0021
433 OESOPHAGEAL ULCER 8 0.0021
434 PARAPLEGIA 6 0.0021
435 CLOSTRIDIUM DIFFICILE COLITIS 22 0.0021
436 HEMIPARESIS 35 0.0021
437 ABNORMAL DREAMS 57 0.0021
438 GENERALISED TONIC-CLONIC SEIZURE 34 0.0021
439 DEPRESSION 465 0.0020
440 VENOUS THROMBOSIS 8 0.0020
441 LUNG INFILTRATION 18 0.0020
442 HYPERPHAGIA 8 0.0020
443 GYNAECOMASTIA 62 0.0020
444 HEPATIC FAILURE 60 0.0020
445 PANCYTOPENIA 111 0.0020
446 DRUG TOXICITY 27 0.0020
447 GLOMERULAR FILTRATION RATE DECREASED 24 0.0020
448 HYPERURICAEMIA 8 0.0019
449 CHOLANGITIS 12 0.0019
450 IMMUNOSUPPRESSION 17 0.0019
451 FAILURE TO THRIVE 10 0.0019
452 DERMATITIS ALLERGIC 24 0.0019
453 HEPATIC FUNCTION ABNORMAL 71 0.0019
454 DRUG EFFECT INCREASED 6 0.0019
455 SUBCUTANEOUS ABSCESS 9 0.0019
456 HYDRONEPHROSIS 14 0.0019
457 MYASTHENIA GRAVIS 15 0.0019
458 TYPE 1 DIABETES MELLITUS 11 0.0018
459 ACUTE CORONARY SYNDROME 15 0.0018
460 SUDDEN DEATH 19 0.0018
461 MULTI-ORGAN FAILURE 31 0.0018
462 CEREBRAL HAEMATOMA 6 0.0018
463 OLIGURIA 11 0.0018
464 BONE MARROW FAILURE 36 0.0018
465 POLYDIPSIA 7 0.0018
466 HEPATIC CYST 6 0.0018
467 TACHYPNOEA 24 0.0018
468 CHOLECYSTITIS ACUTE 10 0.0018
469 BRONCHOPNEUMONIA 6 0.0018
470 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 13 0.0017
471 UNINTENDED PREGNANCY 18 0.0017
472 METABOLIC ACIDOSIS 55 0.0017
473 LIPASE INCREASED 13 0.0017
474 NEONATAL RESPIRATORY DISTRESS SYNDROME 6 0.0017
475 HERPES SIMPLEX 11 0.0017
476 HEMIPLEGIA 14 0.0017
477 ODYNOPHAGIA 10 0.0017
478 HAEMOLYTIC ANAEMIA 15 0.0017
479 CORONAVIRUS INFECTION 11 0.0017
480 SLEEP TERROR 7 0.0017
481 GUILLAIN-BARRE SYNDROME 8 0.0017
482 BLOOD ALBUMIN DECREASED 13 0.0016
483 ALCOHOLISM 7 0.0016
484 AMYLASE INCREASED 6 0.0016
485 GRAND MAL CONVULSION 15 0.0016
486 UVEITIS 22 0.0016
487 PYELONEPHRITIS 14 0.0016
488 RHINITIS 13 0.0016
489 NEPHROTIC SYNDROME 11 0.0016
490 ONYCHOMYCOSIS 7 0.0016
491 NIGHTMARE 54 0.0016
492 LYMPHOPENIA 22 0.0016
493 PERIORBITAL OEDEMA 8 0.0015
494 MALABSORPTION 8 0.0015
495 PANCREATITIS ACUTE 34 0.0015
496 PATENT DUCTUS ARTERIOSUS 6 0.0015
497 CHOLESTASIS 29 0.0015
498 BRAIN OEDEMA 19 0.0015
499 BLOOD SODIUM DECREASED 28 0.0015
500 METASTASES TO LYMPH NODES 10 0.0015
501 DRUG LEVEL DECREASED 15 0.0015
502 LEUKOPENIA 73 0.0015
503 ANHEDONIA 38 0.0014
504 LYMPHOMA 22 0.0014
505 SKIN PLAQUE 12 0.0014
506 BREATH SOUNDS ABNORMAL 7 0.0014
507 BRONCHOPULMONARY ASPERGILLOSIS 11 0.0014
508 HYPOALBUMINAEMIA 11 0.0014
509 DRUG ERUPTION 25 0.0014
510 PROTEIN URINE PRESENT 7 0.0014
511 INTENTIONAL PRODUCT USE ISSUE 123 0.0014
512 HEPATIC ENZYME ABNORMAL 7 0.0014
513 LEFT VENTRICULAR HYPERTROPHY 6 0.0014
514 ASCITES 41 0.0014
515 NEPHROPATHY 13 0.0014
516 BLOOD LACTATE DEHYDROGENASE INCREASED 22 0.0014
517 BLOOD URIC ACID INCREASED 8 0.0014
518 RALES 8 0.0014
519 PERIPHERAL SENSORY NEUROPATHY 8 0.0014
520 FEMORAL NECK FRACTURE 7 0.0014
521 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 35 0.0014
522 LIVER INJURY 33 0.0013
523 APLASTIC ANAEMIA 7 0.0013
524 HEPATOCELLULAR INJURY 19 0.0013
525 GASTRITIS 35 0.0013
526 BLOOD CREATININE INCREASED 86 0.0013
527 END STAGE RENAL DISEASE 24 0.0013
528 CENTRAL NERVOUS SYSTEM LESION 18 0.0013
529 LIVER DISORDER 58 0.0013
530 HAEMATURIA 44 0.0013
531 EPSTEIN-BARR VIRUS INFECTION 8 0.0013
532 SKIN HYPERPIGMENTATION 11 0.0013
533 ARTERIOSCLEROSIS 12 0.0013
534 IMMUNODEFICIENCY 19 0.0013
535 LIVER FUNCTION TEST ABNORMAL 37 0.0013
536 MACULAR OEDEMA 7 0.0012
537 DYSARTHRIA 47 0.0012
538 RASH VESICULAR 6 0.0012
539 HEPATITIS ACUTE 8 0.0012
540 PARKINSONISM 12 0.0012
541 GRANULOCYTOPENIA 7 0.0012
542 TUBULOINTERSTITIAL NEPHRITIS 23 0.0012
543 POLYURIA 10 0.0012
544 SOMNAMBULISM 8 0.0012
545 COORDINATION ABNORMAL 17 0.0012
546 HERPES VIRUS INFECTION 7 0.0012
547 PHOTOSENSITIVITY REACTION 20 0.0012
548 ELECTROLYTE IMBALANCE 14 0.0012
549 HYPOTONIA 12 0.0012
550 ERYSIPELAS 6 0.0012
551 PANCREATITIS 63 0.0012
552 HAEMODIALYSIS 10 0.0012
553 ACUTE KIDNEY INJURY 180 0.0012
554 ABSCESS LIMB 5 0.0012
555 MENTAL DISORDER 51 0.0012
556 HYPOKALAEMIA 54 0.0012
557 DIABETES MELLITUS 89 0.0012
558 CARDIAC MURMUR 10 0.0012
559 ADRENAL INSUFFICIENCY 14 0.0012
560 PALLOR 31 0.0011
561 IMMUNE SYSTEM DISORDER 15 0.0011
562 PAPULE 8 0.0011
563 HYPERCALCAEMIA 14 0.0011
564 SINUS TACHYCARDIA 16 0.0011
565 ANAL ABSCESS 6 0.0011
566 DEVELOPMENTAL DELAY 10 0.0011
567 PYREXIA 380 0.0011
568 MAJOR DEPRESSION 8 0.0011
569 DISEASE RECURRENCE 52 0.0011
570 INTESTINAL ISCHAEMIA 6 0.0011
571 SPINAL COMPRESSION FRACTURE 9 0.0011
572 BLOOD CREATINE PHOSPHOKINASE INCREASED 31 0.0011
573 SKIN TOXICITY 6 0.0011
574 SEPSIS 118 0.0011
575 CARDIOMEGALY 13 0.0011
576 VENTRICULAR SEPTAL DEFECT 6 0.0010
577 MOUTH ULCERATION 22 0.0010
578 BREAST MASS 7 0.0010
579 RASH PAPULAR 23 0.0010
580 RENAL FAILURE 136 0.0010
581 MIDDLE INSOMNIA 19 0.0010
582 RESPIRATORY RATE INCREASED 9 0.0010
583 FACE OEDEMA 17 0.0010
584 RENAL CYST 8 0.0010
585 NEPHROLITHIASIS 46 0.0010
586 RESPIRATORY FAILURE 73 0.0010
587 NEUROPATHY PERIPHERAL 95 0.0010
588 CIRCULATORY COLLAPSE 17 0.0010
589 TOXIC SKIN ERUPTION 10 0.0010
590 DUODENAL ULCER 7 0.0010
591 TOXIC EPIDERMAL NECROLYSIS 15 0.0010
592 SKIN ULCER 25 0.0010
593 HYPOKINESIA 14 0.0010
594 APPENDICITIS 9 0.0010
595 VENTRICULAR EXTRASYSTOLES 10 0.0010
596 CYTOMEGALOVIRUS INFECTION 16 0.0010
597 ACUTE MYELOID LEUKAEMIA 15 0.0010
598 ATRIAL SEPTAL DEFECT 8 0.0010
599 ORAL DISORDER 7 0.0010
600 JOINT STIFFNESS 25 0.0010
601 PSYCHIATRIC SYMPTOM 7 0.0009
602 CEREBRAL DISORDER 7 0.0009
603 NEUTROPENIA 127 0.0009
604 CHRONIC KIDNEY DISEASE 70 0.0009
605 THERAPY CHANGE 9 0.0009
606 AMENORRHOEA 16 0.0009
607 RESPIRATORY DISTRESS 25 0.0009
608 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 7 0.0009
609 CARDIAC FAILURE ACUTE 6 0.0009
610 PERITONITIS BACTERIAL 9 0.0009
611 MYOSITIS 8 0.0009
612 PHARYNGITIS 11 0.0009
613 DISORIENTATION 35 0.0009
614 OSTEONECROSIS 29 0.0009
615 HAEMOGLOBIN DECREASED 90 0.0009
616 TOXICITY TO VARIOUS AGENTS 147 0.0009
617 IRON DEFICIENCY ANAEMIA 8 0.0009
618 EXTRASYSTOLES 6 0.0009
619 HYPERKALAEMIA 30 0.0009
620 SLEEP DISORDER 60 0.0008
621 BACTERAEMIA 10 0.0008
622 NIGHT SWEATS 27 0.0008
623 PNEUMOTHORAX 13 0.0008
624 ERECTILE DYSFUNCTION 21 0.0008
625 HYPOTHYROIDISM 26 0.0008
626 GASTROINTESTINAL DISORDER 72 0.0008
627 GENERAL PHYSICAL HEALTH DETERIORATION 92 0.0008
628 ECONOMIC PROBLEM 12 0.0008
629 ORAL DISCOMFORT 11 0.0008
630 MYOCARDIAL ISCHAEMIA 9 0.0008
631 MYOCARDITIS 9 0.0008
632 DIFFUSE LARGE B-CELL LYMPHOMA 6 0.0008
633 METASTASES TO CENTRAL NERVOUS SYSTEM 10 0.0008
634 NODULE 10 0.0008
635 COMA 36 0.0008
636 CONFUSIONAL STATE 122 0.0008
637 CHROMATURIA 17 0.0008
638 DELIRIUM 26 0.0007
639 SENSORY DISTURBANCE 12 0.0007
640 HYPERTENSION 158 0.0007
641 CARDIOMYOPATHY 11 0.0007
642 RHABDOMYOLYSIS 31 0.0007
643 DRUG WITHDRAWAL SYNDROME NEONATAL 11 0.0007
644 VOMITING 349 0.0007
645 ALTERED STATE OF CONSCIOUSNESS 16 0.0007
646 NO THERAPEUTIC RESPONSE 9 0.0007
647 ASPHYXIA 6 0.0007
648 GASTRIC DISORDER 25 0.0007
649 AFFECT LABILITY 7 0.0007
650 CORONARY ARTERY DISEASE 22 0.0007
651 MYALGIA 123 0.0007
652 POISONING 9 0.0007
653 HYPOXIA 25 0.0007
654 RENAL DISORDER 33 0.0007
655 RENAL INJURY 21 0.0007
656 HEPATIC ENZYME INCREASED 48 0.0007
657 BONE DENSITY DECREASED 22 0.0007
658 ANURIA 6 0.0007
659 HALLUCINATION, AUDITORY 11 0.0007
660 SEPTIC SHOCK 30 0.0007
661 BLOOD CHOLESTEROL INCREASED 32 0.0007
662 CONVULSION 39 0.0007
663 ACUTE RESPIRATORY DISTRESS SYNDROME 12 0.0007
664 SUICIDAL IDEATION 62 0.0007
665 ARRHYTHMIA 32 0.0007
666 GASTROINTESTINAL INFECTION 6 0.0007
667 WEIGHT FLUCTUATION 7 0.0007
668 FEBRILE NEUTROPENIA 44 0.0007
669 ANGINA PECTORIS 19 0.0007
670 SCHIZOPHRENIA 8 0.0007
671 ACIDOSIS 5 0.0007
672 SHOCK 15 0.0007
673 UROSEPSIS 6 0.0006
674 AGITATION 47 0.0006
675 SKIN REACTION 9 0.0006
676 PHOTOPHOBIA 12 0.0006
677 DEHYDRATION 85 0.0006
678 FOOT FRACTURE 12 0.0006
679 VISUAL ACUITY REDUCED 21 0.0006
680 HYPERTENSIVE CRISIS 7 0.0006
681 OBESITY 10 0.0006
682 RASH ERYTHEMATOUS 30 0.0006
683 DYSURIA 23 0.0006
684 DEPRESSED MOOD 33 0.0006
685 PULMONARY HYPERTENSION 13 0.0006
686 PULMONARY EMBOLISM 58 0.0006
687 HERPES ZOSTER 35 0.0006
688 THROMBOCYTOPENIA 68 0.0006
689 DEPRESSED LEVEL OF CONSCIOUSNESS 24 0.0006
690 PERICARDIAL EFFUSION 14 0.0006
691 LIVER FUNCTION TEST INCREASED 13 0.0006
692 EYELID OEDEMA 7 0.0006
693 APHASIA 18 0.0006
694 TYPE 2 DIABETES MELLITUS 20 0.0006
695 MYOCARDIAL INFARCTION 103 0.0006
696 MOTOR DYSFUNCTION 6 0.0006
697 CHOLECYSTITIS 7 0.0006
698 HYPOPHAGIA 15 0.0006
699 EUPHORIC MOOD 6 0.0006
700 ELECTROCARDIOGRAM QT PROLONGED 21 0.0006
701 CORONARY ARTERY OCCLUSION 8 0.0006
702 DIABETIC KETOACIDOSIS 14 0.0006
703 IRRITABILITY 35 0.0006
704 RASH GENERALISED 15 0.0006
705 CEREBRAL INFARCTION 14 0.0006
706 RASH MACULAR 20 0.0006
707 GENERALISED OEDEMA 7 0.0006
708 INTERNATIONAL NORMALISED RATIO INCREASED 16 0.0006
709 POOR QUALITY SLEEP 12 0.0006
710 LETHARGY 32 0.0006
711 BLOOD POTASSIUM INCREASED 9 0.0006
712 HYPERTHYROIDISM 8 0.0006
713 MUSCLE ATROPHY 7 0.0006
714 HAEMATEMESIS 14 0.0006
715 CARDIOVASCULAR DISORDER 14 0.0006
716 HYPONATRAEMIA 31 0.0005
717 CONDITION AGGRAVATED 167 0.0005
718 FEMUR FRACTURE 17 0.0005
719 APATHY 8 0.0005
720 WEIGHT DECREASED 152 0.0005
721 LABORATORY TEST ABNORMAL 16 0.0005
722 ABDOMINAL PAIN 126 0.0005
723 DRUG ABUSE 45 0.0005
724 COAGULOPATHY 9 0.0005
725 DRUG INTOLERANCE 52 0.0005
726 HAEMOPTYSIS 15 0.0005
727 DISTURBANCE IN ATTENTION 29 0.0005
728 BLOOD UREA INCREASED 9 0.0005
729 PLATELET COUNT INCREASED 7 0.0005
730 UPPER GASTROINTESTINAL HAEMORRHAGE 9 0.0005
731 THROMBOSIS 43 0.0005
732 THERAPY NON-RESPONDER 24 0.0005
733 CANDIDA INFECTION 9 0.0005
734 PERITONITIS 11 0.0005
735 VERTIGO 32 0.0005
736 RASH 228 0.0005
737 HYPERGLYCAEMIA 19 0.0005
738 VASCULITIS 6 0.0005
739 DIABETES MELLITUS INADEQUATE CONTROL 9 0.0005
740 COMPLETED SUICIDE 42 0.0005
741 POLYNEUROPATHY 6 0.0005
742 TINNITUS 23 0.0005
743 ANGIOEDEMA 22 0.0005
744 DISSEMINATED INTRAVASCULAR COAGULATION 7 0.0005
745 SUICIDE ATTEMPT 30 0.0005
746 PARALYSIS 7 0.0005
747 SUBDURAL HAEMATOMA 7 0.0005
748 CARDIOGENIC SHOCK 7 0.0005
749 MULTIPLE FRACTURES 8 0.0005
750 RIB FRACTURE 10 0.0005
751 STAPHYLOCOCCAL INFECTION 16 0.0005
752 INFLAMMATION 25 0.0005
753 MYELODYSPLASTIC SYNDROME 7 0.0005
754 ASTHENIA 181 0.0005
755 DIARRHOEA 305 0.0005
756 HAEMORRHAGE INTRACRANIAL 7 0.0005
757 CHOKING 9 0.0005
758 RASH PRURITIC 25 0.0005
759 PLEURAL EFFUSION 28 0.0005
760 INSOMNIA 122 0.0005
761 CHOLELITHIASIS 15 0.0005
762 EOSINOPHILIA 8 0.0005
763 INTERSTITIAL LUNG DISEASE 22 0.0005
764 DYSPHAGIA 43 0.0005
765 HYPERSENSITIVITY 84 0.0005
766 DELUSION 7 0.0005
767 SKIN DISORDER 15 0.0004
768 EYE HAEMORRHAGE 6 0.0004
769 THIRST 8 0.0004
770 DEEP VEIN THROMBOSIS 29 0.0004
771 ABASIA 11 0.0004
772 LEUKOCYTOSIS 8 0.0004
773 SEIZURE 51 0.0004
774 ULCER 7 0.0004
775 PRODUCTIVE COUGH 21 0.0004
776 AGGRESSION 22 0.0004
777 BONE DISORDER 8 0.0004
778 TACHYCARDIA 39 0.0004
779 HALLUCINATION 33 0.0004
780 CONJUNCTIVITIS 8 0.0004
781 MASS 6 0.0004
782 ABNORMAL BEHAVIOUR 17 0.0004
783 COGNITIVE DISORDER 20 0.0004
784 COUGH 120 0.0004
785 MANIA 7 0.0004
786 EPILEPSY 13 0.0004
787 OEDEMA 23 0.0004
788 CARDIAC ARREST 35 0.0004
789 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
790 DIALYSIS 6 0.0004
791 PSYCHOMOTOR HYPERACTIVITY 7 0.0004
792 ABDOMINAL DISTENSION 44 0.0004
793 ANXIETY 119 0.0004
794 FAECES DISCOLOURED 9 0.0004
795 METRORRHAGIA 7 0.0004
796 MOVEMENT DISORDER 13 0.0004
797 NEOPLASM PROGRESSION 14 0.0004
798 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 21 0.0004
799 RESPIRATORY ARREST 11 0.0004
800 HEAD DISCOMFORT 7 0.0004
801 PLATELET COUNT DECREASED 42 0.0004
802 SOMNOLENCE 79 0.0004
803 DEATH 338 0.0004
804 BODY TEMPERATURE INCREASED 8 0.0004
805 CEREBRAL HAEMORRHAGE 14 0.0004
806 ANKLE FRACTURE 6 0.0004
807 DECREASED APPETITE 90 0.0004
808 UNRESPONSIVE TO STIMULI 10 0.0004
809 MUSCULAR WEAKNESS 44 0.0004
810 OSTEOMYELITIS 7 0.0004
811 EJECTION FRACTION DECREASED 6 0.0004
812 OEDEMA PERIPHERAL 47 0.0004
813 RED BLOOD CELL COUNT DECREASED 11 0.0004
814 DEAFNESS 10 0.0004
815 HALLUCINATION, VISUAL 8 0.0004
816 WHITE BLOOD CELL COUNT DECREASED 41 0.0004
817 ABSCESS 6 0.0004
818 THINKING ABNORMAL 7 0.0004
819 PRODUCT USE IN UNAPPROVED INDICATION 92 0.0004
820 PRURITUS GENERALISED 8 0.0004
821 FRACTURE 7 0.0004
822 URINARY TRACT INFECTION 63 0.0004
823 GASTRIC ULCER 7 0.0004
824 NEUTROPHIL COUNT DECREASED 15 0.0004
825 PALPITATIONS 43 0.0004
826 GLAUCOMA 7 0.0004
827 VENTRICULAR TACHYCARDIA 6 0.0004
828 CARDIAC FAILURE 29 0.0004
829 MENTAL STATUS CHANGES 10 0.0004
830 HYPOTENSION 72 0.0004
831 NECK PAIN 20 0.0004
832 C-REACTIVE PROTEIN INCREASED 13 0.0004
833 NAUSEA 279 0.0004
834 LOWER RESPIRATORY TRACT INFECTION 16 0.0004
835 PRESCRIBED UNDERDOSE 7 0.0004
836 METASTASES TO LIVER 6 0.0003
837 LUNG NEOPLASM MALIGNANT 14 0.0003
838 URINARY INCONTINENCE 10 0.0003
839 CHEST PAIN 62 0.0003
840 DERMATITIS 7 0.0003
841 MYELOSUPPRESSION 12 0.0003
842 SYNOVITIS 6 0.0003
843 EMOTIONAL DISTRESS 40 0.0003
844 MOOD ALTERED 9 0.0003
845 URINARY RETENTION 11 0.0003
846 PNEUMONIA 106 0.0003
847 SPEECH DISORDER 17 0.0003
848 AGRANULOCYTOSIS 6 0.0003
849 BRADYCARDIA 17 0.0003
850 DRY MOUTH 26 0.0003
851 PNEUMONIA ASPIRATION 8 0.0003
852 ABDOMINAL PAIN LOWER 8 0.0003
853 BLOOD URINE PRESENT 6 0.0003
854 ADVERSE EVENT 29 0.0003
855 ACUTE RESPIRATORY FAILURE 6 0.0003
856 ORAL HERPES 6 0.0003
857 RESPIRATORY TRACT INFECTION 8 0.0003
858 RESPIRATORY DISORDER 9 0.0003
859 RESTLESSNESS 11 0.0003
860 WEIGHT INCREASED 67 0.0003
861 INFECTION 43 0.0003
862 PRODUCT ADMINISTRATION ERROR 6 0.0003
863 ILL-DEFINED DISORDER 18 0.0003
864 CEREBROVASCULAR ACCIDENT 50 0.0003
865 HYPOAESTHESIA 44 0.0003
866 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 16 0.0003
867 CHILLS 34 0.0003
868 FEELING COLD 8 0.0003
869 CARDIO-RESPIRATORY ARREST 12 0.0003
870 LUNG DISORDER 14 0.0003
871 DYSPNOEA 159 0.0003
872 DIZZINESS 140 0.0003
873 IMPAIRED WORK ABILITY 6 0.0003
874 MALAISE 123 0.0003
875 INCORRECT PRODUCT ADMINISTRATION DURATION 6 0.0003
876 VISION BLURRED 38 0.0003
877 CARDIAC FAILURE CONGESTIVE 22 0.0003
878 EYE DISORDER 9 0.0003
879 HYPOGLYCAEMIA 13 0.0003
880 CARDIAC DISORDER 25 0.0003
881 LOSS OF CONSCIOUSNESS 34 0.0003
882 INTESTINAL OBSTRUCTION 10 0.0003
883 AMNESIA 17 0.0003
884 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
885 HEADACHE 161 0.0003
886 HYPERHIDROSIS 33 0.0003
887 SKIN EXFOLIATION 21 0.0002
888 DISCOMFORT 15 0.0002
889 BLINDNESS 10 0.0002
890 DYSPEPSIA 24 0.0002
891 LIP SWELLING 8 0.0002
892 BONE PAIN 14 0.0002
893 DYSPNOEA EXERTIONAL 9 0.0002
894 CELLULITIS 12 0.0002
895 COVID-19 41 0.0002
896 BLOOD POTASSIUM DECREASED 7 0.0002
897 OFF LABEL USE 203 0.0002
898 OCULAR HYPERAEMIA 11 0.0002
899 SWELLING FACE 15 0.0002
900 ASTHMA 26 0.0002
901 DRUG ADMINISTRATION ERROR 7 0.0002
902 DYSPHONIA 13 0.0002
903 PNEUMONITIS 6 0.0002
904 DISEASE PROGRESSION 26 0.0002
905 PARAESTHESIA 34 0.0002
906 GASTROINTESTINAL HAEMORRHAGE 18 0.0002
907 EPISTAXIS 16 0.0002
908 OXYGEN SATURATION DECREASED 12 0.0002
909 BLOOD PRESSURE DECREASED 14 0.0002
910 OVERDOSE 45 0.0002
911 PRODUCT USE ISSUE 39 0.0002
912 DRUG INEFFECTIVE 272 0.0002
913 OROPHARYNGEAL PAIN 19 0.0002
914 GAIT DISTURBANCE 39 0.0002
915 HAEMORRHAGE 21 0.0002
916 FATIGUE 156 0.0002
917 SYNCOPE 20 0.0002
918 THERAPEUTIC RESPONSE DECREASED 12 0.0002
919 PRURITUS 76 0.0002
920 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
921 ARTHRALGIA 82 0.0002
922 HEART RATE INCREASED 19 0.0002
923 PRODUCT SUBSTITUTION ISSUE 11 0.0002
924 MUSCULOSKELETAL PAIN 10 0.0002
925 CATARACT 11 0.0002
926 STOMATITIS 11 0.0002
927 VIRAL INFECTION 6 0.0002
928 PAIN IN EXTREMITY 53 0.0002
929 ALOPECIA 35 0.0002
930 ADVERSE DRUG REACTION 16 0.0002
931 FALL 59 0.0002
932 CHEST DISCOMFORT 18 0.0002
933 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
934 ECZEMA 9 0.0002
935 HOSPITALISATION 26 0.0002
936 PAIN 99 0.0002
937 ABDOMINAL PAIN UPPER 33 0.0002
938 INTENTIONAL OVERDOSE 10 0.0002
939 RHINORRHOEA 10 0.0002
940 MOBILITY DECREASED 11 0.0002
941 ARTHRITIS 12 0.0002
942 GASTROOESOPHAGEAL REFLUX DISEASE 12 0.0001
943 DRUG EFFECT DECREASED 8 0.0001
944 INFLUENZA LIKE ILLNESS 12 0.0001
945 UNEVALUABLE EVENT 11 0.0001
946 MEDICATION ERROR 8 0.0001
947 NO ADVERSE EVENT 26 0.0001
948 BLISTER 8 0.0001
949 HYPOACUSIS 6 0.0001
950 MEMORY IMPAIRMENT 19 0.0001
951 INTENTIONAL PRODUCT MISUSE 12 0.0001
952 MUSCULOSKELETAL STIFFNESS 12 0.0001
953 ACCIDENTAL OVERDOSE 5 0.0001
954 BACK PAIN 30 0.0001
955 HAEMATOCHEZIA 7 0.0001
956 ABDOMINAL DISCOMFORT 21 0.0001
957 FLUSHING 12 0.0001
958 WHEEZING 7 0.0001
959 BLOOD PRESSURE INCREASED 18 0.0001
960 ERYTHEMA 24 0.0001
961 NERVOUSNESS 6 0.0001
962 TREMOR 19 0.0001
963 BURNING SENSATION 8 0.0001
964 BLOOD GLUCOSE INCREASED 21 0.0001
965 MUSCLE SPASMS 20 0.0001
966 ARTHROPATHY 6 0.0001
967 FLATULENCE 6 0.0001
968 DRUG WITHDRAWAL SYNDROME 9 0.0001
969 FEELING HOT 6 0.0001
970 SWELLING 9 0.0001
971 FEELING ABNORMAL 23 0.0001
972 URTICARIA 15 0.0001
973 INJURY 6 0.0001
974 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
975 BALANCE DISORDER 7 0.0001
976 DYSGEUSIA 6 0.0001
977 VISUAL IMPAIRMENT 10 0.0001
978 CONSTIPATION 17 0.0001
979 ATRIAL FIBRILLATION 7 0.0001
980 CONTUSION 6 0.0001
981 NASOPHARYNGITIS 11 0.0001
982 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
983 JOINT SWELLING 7 0.0001
984 DRUG DOSE OMISSION 9 0.0001
985 INFLUENZA 6 0.0001
986 DRY SKIN 6 0.0000
987 DRUG DEPENDENCE 6 0.0000
988 INCORRECT DOSE ADMINISTERED 7 0.0000